James Wilson
Vermögen: 105 Mio $ am 31.05.2026
Vermögen: 105 Mio $ am 31.05.2026
Mr. James N.
Wilson is a Chairman at Corcept Therapeutics, Inc. He is on the Board of Directors at The Palo Alto Medical Foundation.
Mr. Wilson was previously employed as a Lead Independent Director by Amylin Pharmaceuticals, Inc., a Chairman by Amira Medical, Inc., a President & Chief Operating Officer by Syntex Corp., a Chairman & Chief Executive Officer by Neurex Corp., and a Chief Executive Officer by Lifescan, Inc. He also served on the board at NuGEN Technologies, Inc., A Stepping Stone Foundation and Insight Prison Project.
He received his undergraduate degree from the University of Arizona and an MBA from the University of Arizona.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.05.2026 | 1’504’543 ( 1.4% ) | 105 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Vorsitzender | 01.01.1999 |
The Palo Alto Medical Foundation
The Palo Alto Medical Foundation Hospital/Nursing ManagementHealth Services Provides medical services | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
Tecan Genomics, Inc.
Tecan Genomics, Inc. Electronic Equipment/InstrumentsElectronic Technology Provides genomics sample preparation solutions | Vorsitzender | - |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Direktor/Vorstandsmitglied | 01.06.2009 |
Amira Medical, Inc.
Amira Medical, Inc. Medical SpecialtiesHealth Technology Develops and markets glucose monitoring products | Vorsitzender | 01.01.2001 |
Syntex Corp.
Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Präsident | 01.01.1994 |
Neurex Corp.
Neurex Corp. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Vorstandsvorsitzender | 01.01.1990 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Neurex Corp.
Neurex Corp. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Syntex Corp.
Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Corcept Therapeutics, Inc.
Corcept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of drugs which treat severe metabolic, oncologic and neuropsychiatric disorders | Health Technology |
Tecan Genomics, Inc.
Tecan Genomics, Inc. Electronic Equipment/InstrumentsElectronic Technology Provides genomics sample preparation solutions | Electronic Technology |
Amira Medical, Inc.
Amira Medical, Inc. Medical SpecialtiesHealth Technology Develops and markets glucose monitoring products | Health Technology |
University of Arizona
University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lifescan, Inc.
Lifescan, Inc. Medical/Nursing ServicesHealth Services Manufactures health care products | Health Services |
The Palo Alto Medical Foundation
The Palo Alto Medical Foundation Hospital/Nursing ManagementHealth Services Provides medical services | Health Services |
A Stepping Stone Foundation
A Stepping Stone Foundation Miscellaneous Commercial ServicesCommercial Services Provides preschool educational services | Commercial Services |
Insight Prison Project
Insight Prison Project Miscellaneous Commercial ServicesCommercial Services Offers transformational programs for prisoners and parolees | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen